Welcome to the
NagiBio News & Blog
-
The SERI-funded EIC Accelerator program grants Nagi Bioscience with €2.5 million to accelerate development and commercial scale-up of their unique ‘Organism-on-Chip’ product
21/03/22 – Press Release
Professing the transition to the new era of biological testing as our vision, being selected by the EIC Accelerator program is going to be crucial to make Nagi’s vision a reality.
-
Alternative Testing Methods
17/03/22 – Blog Post
The new biotech horizon with an expected 10% annual growth from 2022 to 2025.
-
Meet our new Team Members!
10/03/22 – Blog Post
The revolution of innovative and ethical biological testing counts today with three new talents!
-
The C. elegans Nobel Prizes
03/11/21 – Blog Post
Learn more about the Nobel Prizes that were awarded to C. elegans researchers.
-
How C. elegans can bridge the gap between cells and mouse
21/10/21 – Blog Post
How c. elegans can be a sustainable and cost-effective solution bridging the gap between cells and vertebrates.
-
Nagi’s team is growing!
28/09/21 – Blog Post
Our Nagi Bioscience’s team is expanding! We welcome Alexandre Vaudano, who will be working as an Intern in charge of Business Development and Marketing.
-
W.A. De Vigier Stiftung startup competition finalist
12/05/21 – News Article
Nagi Bioscience was selected as a finalist of the prestigious W.A. De Vigier Stiftung startup competition in 2021.
-
Nagi Bioscience was selected as part of the EU funded “HealthAge” project
01/05/21 – News Article
Nagi Bioscience was selected as part of the EU-funded “HealthAge” project.
-
Nagi Bioscience was awarded an Innosuisse Innovation Project in 2020
01/03/21 – News Article
Nagi Bioscience was awarded an Innosuisse Innovation Project in 2020.
-
Nagi Bioscience was named as a TOP 100 Swiss startups and TOP 10 newcomers of 2020
09/09/20 – News Article
Nagi Bioscience was named as a TOP 100 Swiss startups and TOP 10 newcomers of 2020. And we did it again this year 2022! We have been nominated for TOP 100 Swiss…
-
Nagi Bioscience listed in Bilan’s TOP 50 Swiss start-up companies 2020!
11/03/20 – News Article
Nagi Bioscience was selected by the prestigious Swiss economic newspaper Bilan among the Top 50 startups in which to invest in 2020.
-
Nagi Bioscience is proud to announce the closing of a CHF 1.8M seed financing round
20/12/19 – Press Release
Nagi Bioscience raises CHF 1.8 Million to accelerate its mission of setting a new standard for testing safety and efficacy of drugs and chemicals.